What is the project work plan?

The overall objective of the PERISCOPE consortium is to accelerate the development and registration of novel pertussis vaccines. Pivotal to this is the identification of novel biomarkers of protection and the development of models that can be used to expedite preclinical and clinical testing, and selection of the most effective candidates for licensing. To achieve these objectives, the project is divided into seven distinct work packages:

PERISCOPE members will establish a dialogue with European regulatory authorities and Public Health Institutions. This will facilitate collaboration with representatives of these bodies on incorporation of our findings into Regulatory Guidance and Public Health guidelines for best use of existing and novel vaccines. This also includes evaluation of immunization in pregnancy in settings where wP vaccination is the standard for infants.